08:00 , Feb 27, 2012 |  BC Week In Review  |  Clinical News

CardioGen-82 regulatory update

FDA approved an updated label for Bracco's CardioGen-82 to include a black box warning on unintended exposure to strontium-82 and strontium-85 radiation. The updated label also includes new "Alert Limits" for strontium-82 and strontium-85 levels...
07:00 , Sep 29, 2008 |  BC Week In Review  |  Company News

Bracco Imaging S.p.A., Lantheus sales and marketing update

The companies will co-promote Bracco's CardioGen-82 to distinguish normal from abnormal myocardium in patients with suspected myocardial infarction (MI). The myocardial perfusion positron emission tomography (PET) imaging agent was approved by FDA in 1989. Financial...